Skip to content

13F-HR filed by Crestline Management, L.P.

Crestline Management, L.P. filed this 13F-HR for the quarter ended 2026-09-30, accepted by EDGAR 2026-11-16 18:37:59 UTC, with 2 holding rows worth $29,295,800.

Accession
0001315863-26-000783
Filed
2026-11-16
Accepted by EDGAR
Ingested
Source
EDGAR live feed

Original filing

13F report for Q3 2026

A holdings report, 2 entries on the cover page, a total value of $29,295,800 stated on the cover page (in dollars after the unit check, H1), rows summing to $29,295,800 with VALUE read as dollars as filed, 13F file number 028-14917. The quarter's positions are built on this report. The resolved quarter.

Other managers

  • included managerRithm Capital Corp. 028-25604

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
DENALI THERAPEUTICS INC COM24823R105Stock1,310,732$27,092,830dollars as filed
SANA BIOTECHNOLOGY INC799566104COM755,736$2,202,970dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001315863-26-000783this filing2026-11-16